JohnKaczmarMD

PubMed

• 1 citations
  Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.
  Julie E Bauman, Nabil F Saba, Denise Roe, Jessica R Bauman, John Kaczmar, Aarti Bhatia, Jameel Muzaffar, Ricklie Julian, Steven Wang, Shethal Bearelly, Audrey Baker, C...> ;Journal of Clinical Oncology. 2023 Aug 1
• The Inconsistent Assessment of Quality of Life in Patients Treated for Head and Neck Cancer with Anti-EGFR Inhibitors: A Systematic Scoping Review.
  Sarah R Sutton, April N Taniguchi, Shaun A Nguyen, William G Albergotti, John M Kaczmar, Alexandra E Kejner, Jason G Newman> ;Cancers. 2023 Apr 26
• Programmed death 1 (PD-1) and ligand (PD-L1) inhibitors in head and neck squamous cell carcinoma: A meta-analysis.
  Dylan A Levy, Jaimin J Patel, Shaun A Nguyen, W Nicholas Jungbauer, David M Neskey, Ezra E W Cohen, Chrystal M Paulos, John A Kaczmar, Hannah M Knochelmann, Terry A Day> ;World Journal of Otorhinolaryngology - Head and Neck Surgery. 2022 Sep 1
• 32 citations
  Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma.
  Trisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, Benjamin H Hinrichs, Francis P Worden, Matthew O Old, Neal E Dunlap, John M Kaczmar, Yash Patil, Muhammed Kash...> ;Clinical Cancer Research. 2022 Apr 1
• 2 citations
  Immune Checkpoint Inhibitors for Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis.
  Neil K Mehta, Andraia R Li, Shaun A. Nguyen, John M. Kaczmar, David M. Neskey, Terry A. Day> ;Targeted Oncology. 2021 Oct 22
• 28 citations
  Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma
  Hannah M. Knochelmann, Joshua D. Horton, Sixue Liu, Kent Armeson, John M. Kaczmar, Megan Wyatt, Mary S. Richardson, Shirley H. Lomeli, Ying Xiong, Evan M. Graboyes, Er...> ;Cell Reports. Medicine. 2021 Oct 19
• 12 citations
  Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head...
  Evan M. Graboyes, Katherine R. Sterba, Hong Li, Graham W. Warren, Anthony J. Alberg, Elizabeth A Calhoun, Brian Nussenbaum, Jessica McCay, Courtney H. Marsh, Nosayaba ...> ;JCO Oncology Practice. 2021 Mar 10
• 2 citations
  Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation:
  Flora Yan, Hong Li, John R. de Almeida, John M. Kaczmar, Joseph Zenga, Mary S. Richardson, David M. Neskey, Anand K. Sharma, Terry A. Day, Evan M. Graboyes, Patrik Pip...> ;Otolaryngology--Head and Neck Surgery. 2021 Feb 23
• Montelukast-Based Premedication Regimen for Recurrent Cetuximab Infusion-Related Reactions
  Amy Sion, Lyndsey Milburn, John M. Kaczmar> ;JCO Oncology Practice. 2021 Jan 1
• 13 citations
  Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis
  Lane B. Donaldson, Flora Yan, Patrick F Morgan, John M. Kaczmar, Jyotika K. Fernandes, Shaun A. Nguyen, Rachel L Jester, Terry A. Day> ;Endocrine. 2021 Apr 1
• 23 citations
  Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer.
  Evan M. Graboyes, Chanita Hughes Halbert, Hong Li, Graham W. Warren, Anthony J. Alberg, Elizabeth Calhoun, Brian Nussenbaum, Courtney H. Marsh, Jessica McCay, Terry A....> ;JCO Oncology Practice. 2020 Aug 27
• 9 citations
  Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
  Flora Yan, Hong Li, John M. Kaczmar, Anand K. Sharma, Terry A. Day, David M. Neskey, Joseph Zenga, Evan M. Graboyes> ;JAMA Otolaryngology-- Head & Neck Surgery. 2020 Dec 1
• 14 citations
  The evolution of care of cancers of the head and neck region: State of the science in 2020
  Flora Yan, Hannah M. Knochelmann, Patrick F Morgan, John M. Kaczmar, David M. Neskey, Evan M. Graboyes, Shaun A. Nguyen, Besim Ogretmen, Anand K. Sharma, Terry A. Day> ;Cancers. 2020 Jun 11
• 30 citations
  The neoadjuvant paradigm reinvigorated: a review of pre-surgical immunotherapy in HNSCC.
  Margaret A. Stafford, John M. Kaczmar> ;Cancers of the Head & Neck. 2020 Mar 16
• 18 citations
  Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge
  James Kalmuk, Jon Puchalla, Gong Feng, Anshu Giri, John M. Kaczmar> ;Cancers of the Head & Neck. 2020 Feb 3
• 44 citations
  Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival
  Evan M. Graboyes, Mark A. Ellis, Hong Li, John M. Kaczmar, Anand K. Sharma, Eric J. Lentsch, Terry A. Day, Chanita Hughes Halbert> ;Cancer. 2018 Aug 1
• 43 citations
  Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer
  Mark A. Ellis, Evan M. Graboyes, Amy E. Wahlquist, David M. Neskey, John M. Kaczmar, Heather K. Schopper, Anand K. Sharma, Patrick F Morgan, Shaun A. Nguyen, Terry A. Day> ;Otolaryngology--Head and Neck Surgery. 2018 Apr 1
• 53 citations
  HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery
  John M. Kaczmar, Kay See Tan, Daniel F. Heitjan, Alexander Lin, Peter H. Ahn, Jason G. Newman, Christopher H. Rassekh, Ara A. Chalian, Bert W. O'Malley, Roger B. Cohen...> ;Head & Neck. 2016 Jan 1
• 3 citations
  The efficacy of ceritinib in patients with ALK-positive non-small cell lung cancer.
  John M. Kaczmar, Ranee Mehra> ;Therapeutic Advances in Respiratory Disease. 2015 Jul 30
• 15 citations
  Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck.
  Tim N. Beck, John M. Kaczmar, Elizabeth Handorf, Anna S. Nikonova, Cara Dubyk, Suraj Peri, Miriam N. Lango, John A. Ridge, Ilya G. Serebriiskii, Barbara Burtness, Eric...> ;Oncotarget. 2015 May 29
• HPV-negative head and neck squamous cell carcinomas: how can we use the tumor protein signature?
  John M. Kaczmar, Ranee Mehra> ;Biomarkers in Medicine. 2015 Mar 3
• Join now to see all